Melanotan II is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH), developed to stimulate melanogenesis, enhance UV protection, and modulate sexual and metabolic functions. It acts as a non-selective agonist of melanocortin receptors, particularly MC1R, MC3R, and MC4R.
Originally studied for its tanning and photoprotective properties, Melanotan II has also shown effects on libido enhancement, appetite suppression, and energy balance, making it a multifunctional research peptide with interest in dermatology, endocrinology, and sexual medicine.
Melanotan II works by activating several melanocortin receptors:
MC1R: Stimulates melanin production → increases skin pigmentation and UV protection
MC3R / MC4R: Involved in appetite control, libido enhancement, and energy homeostasis
Crosses the blood-brain barrier, influencing central neurohormonal pathways
Although not approved for medical use, Melanotan II is widely studied for the following:
Promotes eumelanin synthesis, leading to natural tanning
Provides photo-protective effects without sun exposure
Potential for reducing skin cancer risk in fair-skinned individuals
Shown to increase libido and sexual arousal in both men and women
Studied as a potential therapy for erectile dysfunction (ED) via MC4R activation
May reduce appetite and food intake by acting on hypothalamic pathways
Potential adjunct in obesity research
High purity ≥ 99% (HPLC & LC-MS confirmed)
Synthesized via solid-phase peptide synthesis (SPPS)
Low endotoxin, low residual solvents
Available in R&D to commercial scale